Net value change of +$9.17B, 1,298 buyers vs 1,035 sellers, and 240 new positions against 145 exits. Insider data is absent, but institutional flows alone provide a clear accumulation signal.

Confirmation

Sustained net buying in the next 13F filing would confirm the upward institutional trend.

Invalidation Risk

A flip to net institutional selling or an adverse corporate event would break the bullish thesis.

AI-generated from public SEC disclosures and limited to historical data. Should not be relied upon as the sole basis for any investment decision.

Insider Trading (Form 4)

12-Month Buy/Sell Activity

Feb 25

Aug 25

BuySell

Action	Insider	Title	Date	Value
Sell	Elkins David V	EVP, Chief Financial Officer	2025-09-02	$2.65M
Sell	Short Bartie Wendy	EVP, Corporate Affairs	2025-08-02	$17K
Sell	Hickey Benjamin	President, RayzeBio Org.	2025-05-09	$4K
Buy	Hirawat Samit	EVP,Chief Med.Offr.,Drug Dev.	2025-04-25	$202K
Buy	BOERNER CHRISTOPHER S.	Chief Executive Officer	2025-02-20	$110K
Buy	Hirawat Samit	EVP,Chief Med.Offr.,Drug Dev.	2025-02-14	$100K

View all insider trades →

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding BRISTOL-MYERS SQUIBB CO (BMY)?

Major stakeholders currently include BlackRock, Inc. ($10.4B), Vanguard Capital Management LLC ($8.0B), State Street CORP ($6.0B). Based on the latest 13F filings, there are a total of 2537 tracked investment funds and institutions maintaining positions in BMY.

What is the overall institutional sentiment toward BMY recently?

Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $9.2B, driven by 1298 managers accumulating shares while 1036 reduced their exposure.

Which institutions have been selling or reducing their BMY positions?

In the latest period, 890 funds trimmed their holdings, and 146 managers completely exited their positions. The aggregate reported sell value was $43.8B.

Are there any notable investors adding BMY to their portfolios?

Yes, buying activity remains notable. 240 institutions opened new positions in {ticker}, and 1058 existing holders added to their shares. The total reported buy value for the quarter amounted to $48.9B.